|Articles|April 1, 2001
- Pharmaceutical Executive-04-01-2001
- Volume 0
- Issue 0
Regulation: Two-Track Plan
Author(s)Kevin Gopal
Brussels-Two types of mutual recognition procedures are necessary to ensure that generics get to market as quickly as possible, according to the European Generics Medicines Association.
Advertisement
Articles in this issue
almost 25 years ago
Internet DTC - Minding Your P's & Q'salmost 25 years ago
Policy: Tectonic Shiftalmost 25 years ago
Liberated?almost 25 years ago
A Matter of Tastealmost 25 years ago
Partnerships: Bargaining Biotechsalmost 25 years ago
Pediatric Mandatealmost 25 years ago
Genentech's Passion for Patientsalmost 25 years ago
Regulation: OK After AllNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
2
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
3
What Governance Resets Should Pharma Companies Take in Response to AI?
4
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
5